Search Options Stock News and Analysis from Schaeffer's

Moderna Stock Options Pop After Earnings, FDA Update

https://www.schaeffersresearch.com/content/news/2023/02/23/moderna-stock-options-pop-after-earnings-fda-update

2/23/2023 11:17 AM

Moderna Inc (NASDAQ:MRNA) stock is down 7% at $147.10 at last check, after the company's lackluster fourth-quarter earnings report offset some upbeat Food and Drug Administration (FDA) news. Spec...

Checking in with Merck Stock Before Earnings

https://www.schaeffersresearch.com/content/news/2023/01/31/checking-in-with-merck-stock-before-earnings

1/31/2023 3:03 PM

Pharmaceutical company Merck & Co (NYSE:MRK) is one of the many big names set to announce its quarterly report this week, with earnings scheduled before the open on Thursday, Feb. 2. Wall Street anti...

Rallying Merck Stock Flashing Historically Bullish Signal

https://www.schaeffersresearch.com/content/analysis/2022/11/28/rallying-merck-stock-flashing-historically-bullish-signal

11/28/2022 1:59 PM

A week after announcing its acquisition of Imago Biosciences (IMGO), things are looking up for pharmaceutical concern Merck & Co Inc (NYSE:MRK). The shares just secured their sixth-straight all-time ...

Merck Making Moves, to Acquire Imago Biosciences

https://www.schaeffersresearch.com/content/news/2022/11/21/merck-making-moves-to-acquire-imago-biosciences

11/21/2022 9:05 AM

Merck & Co., Inc. (NYSE:MRK) is set to acquire biopharmaceutical company Imago Biosciences Inc (NASDAQ:IMGO) in a cash deal worth $1.35 billion. Merck will pay $36 per share, or a 106.9% premium to I...

Recession Warning Caps Off Volatile Week on Wall Street

https://www.schaeffersresearch.com/content/news/2022/09/16/recession-warning-caps-off-volatile-week-on-wall-street

9/16/2022 1:06 PM

The past five days were nothing short of a roller coaster, after the major indexes last week scored a much-needed win. Key inflation data rolled in, while initial jobless claims fell for the fifth c...

PEOPLE ALSO SEARCH FOR